NCT05729594View on ClinicalTrials.gov

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

April 5, 2023

Study Completion Date

April 5, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Bimatoprost Ophthalmic

eyedrops

Trial Locations (1)

07103

Biotrial, Newark

Sponsors

Lead Sponsor

Laboratoires Thea

All Listed Sponsors

lead

Laboratoires Thea

INDUSTRY